Literature DB >> 18161174

[Economical viewpoint for treatment of osteoporosis].

Yasufumi Hayashi1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18161174

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN： 0047-1852


× No keyword cloud information.
  5 in total

1.  Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.

Authors:  T Mori; C J Crandall; D A Ganz
Journal:  Osteoporos Int       Date:  2017-02-17       Impact factor: 4.507

2.  A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.

Authors:  M Yoshimura; K Moriwaki; S Noto; T Takiguchi
Journal:  Osteoporos Int       Date:  2016-10-14       Impact factor: 4.507

3.  Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.

Authors:  K Moriwaki; H Fukuda
Journal:  Osteoporos Int       Date:  2019-01-04       Impact factor: 4.507

4.  Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.

Authors:  K Moriwaki; S Noto
Journal:  Osteoporos Int       Date:  2016-10-04       Impact factor: 4.507

5.  Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.

Authors:  K Moriwaki; M Mouri; H Hagino
Journal:  Osteoporos Int       Date:  2017-03-06       Impact factor: 4.507
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.